Bio-Stuff (BARZ) 0.0924 $BARZ 5BARz Accelerates Capital

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bio-Stuff (BARZ) 0.0924 $BARZ

5BARz Accelerates Capital Raising and Business Development in India
BusinessWire - Tue Mar 29, 8:30AM CDT
5BARz International, Inc., (OTCQB: BARZ), (www.5barz.com) ("5BARz" or "the Company" a technology leader in the cellular network extender industry, is pleased to announce that it has topped off a private placement completed by the Company with the recent equity investment of $1,110,000. In the past two weeks, $1,110,000 has been invested under the terms of an offering memorandum and reported on Form 8K also filed with the SEC. (See details of the offering at www.sec.gov under the 5BARz filings, and 5BARz data at www.otcqb.com ).

5BARz India Becomes Approved Vendor for Another Tier 1 Cellular Network Operator in India
BusinessWire - Tue Mar 15, 5:00AM CDT
5BARz International, Inc., (OTCQB: BARZ), (www.5barz.com) ("5BARz" or "the Company" a technology leader in the cellular network extender industry, is pleased to announce that through our wholly owned subsidiary, 5BARz India Pvt. Ltd., we have been engaged to provide the 5BARz Network extender device to a second Tier 1 Cellular Network operator in India. The initial purchase order from this network operator follows an extensive program of field testing and laboratory tests, and a review process of almost one year. As a result the Company has become an approved vendor to this industry's leading Cellular Network operator.

Vodafone Continues Commercial Roll out of 5BARz in India
BusinessWire - Thu Dec 24, 8:00AM CST
5BARz International, Inc., (OTCQB: BARZ), (www.5barz.com) ("5BARz" or "the Company" a technology leader in the cellular network extender industry, is pleased to announce that through our wholly owned subsidiary, 5BARz India Pvt. Ltd., Vodafone India Limited has issued a follow on purchase order to their initial purchase orders previously announced this past summer. This follow on purchase order is the next step in the commercial roll out of the 5BARz(R) Network Extender onto the Vodafone India network (www.vodafone.in).
VOD: 30.91 (+0.43)

Here is Former Apple CEO Gil Amelio's New Tech Darling
PR Newswire - Tue Oct 27, 7:35AM CDT
Born2Invest, a wholly-owned subsidiary of UK-based M6 Limited today started featuring 5BARz International Inc. (OTCQB: BARZ). Former Apple Chairman and CEO Gil Amelio believes he has found the opportunity of a lifetime. As the current Chairman of San Diego-based 5BARz International Inc., the team under his watch has developed a plug-and-play device that strengthens weak cellular signals. Marketed under the brand name 5BARz, the technology delivers high quality signals for voice, data and video reception on cell phones and other cellular equipped devices.
NSM: 11.45 (+0.09)

5BARz India Sales and Marketing Team Expansion
BusinessWire - Tue Oct 27, 6:23AM CDT
5BARz International, Inc. (OTCQB: BARZ), (www.5BARz.com) ("5BARz" or "the Company" a technology leader in the cellular network extender industry, is pleased to announce the hire of Mr. Alok Kiran Divatia as VP of Sales and Marketing for 5BARz India, a wholly owned subsidiary of 5BARz International, Inc.

United Capital Adds Two Pioneers to its Parent Company's Board
BusinessWire - Thu Mar 12, 10:30AM CDT
United Capital Financial Advisers, LLC today announces the appointments of Andrew Rudd, Ph. D., Chairman and CEO of Advisor Software Inc., and Arthur Rubinfeld, Chief Creative Officer and President, Global Innovation, at Starbucks, and author of "Built for Growth," to the Board of Directors of its parent company, United Capital Financial Partners, Inc. For United Capital, these thought leaders add specialized expertise to the board and signal focus areas for the firm's strategy.

5BARz India Hires Top Telecom Executive to Run Company
BusinessWire - Thu Mar 12, 5:00AM CDT
5BARz International, Inc. (OTCQB: BARZ), (www.5BARz.com) ("5BARz" or "the Company" a technology leader in the cellular network extender industry, is pleased to announce that its subsidiary 5BARz India has hired Samartha Raghava Nagabhushanam to serve as Managing Director and CEO.

5BARz Engages David Habiger as Member of Advisory Board
BusinessWire - Thu Jan 29, 5:01AM CST
5BARz International, Inc. (OTCQB: BARZ), (www.5BARz.com) ("5BARz" or "the Company" a technology leader in the cellular network extender industry, is pleased to announce that David "Dave" Habiger, an industry veteran and Senior Advisor at Silver Lake Partners and Venture Partner at Pritzker Group Venture Capital, will be joining its Advisory Board. 5BARz has made a concentrated effort to hire top talent and strengthen its advisors.
ROVI: 17.27 (+0.20)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 8

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 9

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 6

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing $1000 in Lockheed Martin: A Decade of Growth

Updated Category News Views 91

Unlocking the Power of $1000: The Journey of Lockheed Martin Lockheed Martin has excelled in the stock market, delivering impressive returns for investors who bought shares a decade ago. With a current market capitalization of $138.10 billion, this defense powerhouse has consistently outperformed the market, achieving an annualized growth rate that surpasses expectations....

Continue Reading
Fortis Financial Performance Update: Q4 Earnings Insights

Updated Category News Views 169

Fortis Financial Performance Overview Fortis (NYSE: FTS) has recently shared its Q4 earnings results, revealing strong performance that is worth a closer look. The company's earnings announcement not only highlights its financial health but also offers insights for investors and stakeholders alike. Earnings Highlights In its latest announcement, Fortis exceeded earnings...

Continue Reading
Flowers Foods Increases Quarterly Dividend to $0.24 Per Share

Updated Category News Views 100

Flowers Foods Declares Increased Quarterly Dividend Flowers Foods, Inc. (NYSE: FLO) has recently taken significant steps in its financial directives by announcing a quarterly dividend of $0.24 per share. This marks a commendable increase of 4.3% compared to the same quarter last year. Impressively, this is the 90th consecutive quarterly dividend paid by the company....

Continue Reading
Freeport McMoRan Adjusts Copper Sales Amid Production Setbacks

Updated Category News Views 65

Freeport McMoRan to Delay Indonesian Copper Sales Freeport McMoRan, a significant player in the copper mining industry, has announced a postponement of its refined copper sales from Indonesia to the second quarter of 2025. This decision follows a fire incident at its new smelter, causing an unexpected delay in production. Production Challenges at Manyar Smelter The Manyar...

Continue Reading
Snowflake and Palantir: Revolutionizing AI in Data Management

Updated Category News Views 240

Understanding the Important Deal Between Snowflake and Palantir Snowflake Inc. (NYSE: SNOW) has recently entered a significant partnership with Palantir Technologies Inc. (NYSE: PLTR), marking an important milestone in its ambitious journey towards enhancing artificial intelligence (AI) capabilities for businesses. This collaboration aims to foster enterprise AI...

Continue Reading